As of 2026-01-05, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (24.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -227.6%.
The range of the Relative Valuation is (24.49) - (27.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 18.9x | 15.4x |
| Forward P/E multiples | 16.6x - 21.7x | 17.5x |
| Fair Price | (24.49) - (27.91) | (24.24) |
| Upside | -228.9% - -246.9% | -227.6% |
| Date | P/E |